Fritextsökning
Innehållstyper
-
Sweden is heavily criticised for not ordering Covid vaccine
Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
Exakt reglering vid låga cylinderhastigheter
Kör du dina cylindrar i intervallet 1–150 mm/s? Nya AS-FM/FC är en strypbackventil för finjustering och hög noggrannhet vid låga hastigheter.
-
Investcorp förvärvar Sanos Group
Investcorp förvärvar CRO-bolaget Sanos Group som är specialiserade på artrosforskning.
-
Skånskt medtech-bolag får ny storägare
Fåhraeus Startup & Growth Fund går in som en av huvudägarna i medtech-bolaget Airsonett.
-
Tataa inrättar vetenskapligt råd
Tataa Biocenter bildar ett rådgivande vetenskapligt råd. Nu har de fem första experterna i rådet utsetts.
-
Amorphous materials take centre stage when Orexo develops new formulations
Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...
-
Norway finds its path in life science
The life science sector in Norway is on the rise.
-
Marie Gårdmark: New incentives for orphan products on its way
"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...
-
“Everyone is screaming for talent”
Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...
-
Paolo Macchiarini in court – “The sole intent was to cure”
Paolo Macchiarini’s surgical procedure was illegal, life-threatening and caused severe and prolonged suffering to patients the prosecution claimed when the tria...
-
Oväntat stort mörkertal för TBE-infektioner – ”Vi blev väldigt överraskade”
En ny studie tyder på att infektioner av det fästingburna TBE-viruset är långt vanligare i Sverige än man hittills trott.
-
New rules for diagnostic products, but who will certify them? “An extreme shortage area”
In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...
-
Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”
“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...
-
No demand for new Covid vaccine – “It will probably be discarded”
So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...
-
Collaboration for a simpler production of gene therapies launched
A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...
-
Start-up developing ”digital twin” received award during the EIT Health Summit
A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.
-
When carelessness, forgetfulness and coincidence become the researcher’s best friend
Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...
-
Coordination of world-class research facilities
Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...
-
Tougher competition as the Novo Nordisk Foundation broadens its programme
Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...
-
Hansa tar in 372 miljoner inför USA-lansering: "Starkt intresse"
Lundbaserade Hansa Biopharma har tagit in 372,2 miljoner kronor i en riktad nyemission där flera amerikanska specialistinvesterare deltar.
-
Now it’s settled: The International Vaccine Institute will be located in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...
-
Rekordmånga biotech-konkurser i USA
Fjolåret var tufft för många företag inom biotech. I USA var antalet konkurser i branschen det högsta sedan 2010, visar en sammanställning.
BREAKING